My BMJ editorial: how can we stop academic press releases misleading the public?
There is an excellent research paper published today in the BMJ, showing that academic press releases routinely exaggerate scientific findings and mislead the public. This is something I’ve often...
View ArticleRichard Herring Leicester Square Theatre Show, interview, video…
I took great pride in the fact that my book Bad Science was first reviewed by Viz and the British Medical Journal. In that vein, here’s a 90 minute interview I did on stage with comedian Richard...
View ArticleI did a Newsnight thing about how politics needs better data
Here’s a 5 minute film I did on Newsnight last week, about how politics needs better data. Specifically, it’s about how politicians misuse statistics, how we can stop them, and how we can generate...
View ArticleWHO announcement on withheld clinical trials, and my commentary in PLoS Medicine
As you’ll hopefully know by now from reading Bad Science, Bad Pharma, and my endless columns on the subject, medicine has a problem: the results of clinical trials are routinely and legally withheld...
View ArticleTwo interviews on withheld trials, NPR and ABC
Here are a couple of fairly detailed interviews I’ve done over the last two weeks, both on the problem of clinical trial results being withheld. The first is with On The Media, an excellent NPR show,...
View ArticleNew BMJ editorial: “How Medicine is Broken, and How We Can Fix It”
There are some big problems in medicine, and the public are right to be concerned about our shortcomings. Last week we found out that the Chief Medical Officer has written to the Academy of Medical...
View ArticleFixing flaws in science must be professionalised. By me in the Journal of...
Me and a dozen other academics all just wrote basically the same thing about Open Science in the Journal Of Clinical Epidemiology. After the technical bits, me and Tracey get our tank out. That’s for a...
View ArticleSo this company Cyagen is paying authors for citations in academic papers.
Here’s a strange thing, a seedy curio rather than a massive scandal, but I’d be interested to know what you make of it. This week lots of academics all received the same unsolicited marketing email...
View ArticleBan academics from talking to ministers? We should train them to do it!
The Cabinet Office has come up with a crazy plan to ban academics like me from talking to politicians and civil servants. In this piece I explain why that is an almost surreally stupid idea. I also...
View ArticleEvents in Sydney, Melbourne, Brisbane, Auckland
Hi there, I’m doing a few events in Australia and NZ this week: in Sydney, Melbourne, Auckland (only 25 tickets left), and Brisbane. Here‘s a good fun interview I did with The Conversation that gets...
View ArticleTaking transparency beyond results: ethics committees must work in the open
Here’s a useful paper we’ve just published in the BMJ, documenting problems in transparency around approval processes for randomised trials. There’s a basic rule in clinical research: you’re only...
View ArticleThe Cancer Drugs Fund is producing dangerous, bad data: randomise everyone,...
There are recurring howls in my work. One of them is this: in general, if you don’t know which intervention works best, then you should randomise everyone, everywhere. This is for good reason:...
View ArticleSarepta, eteplirsen: anecdote, data, surrogate outcomes, and the FDA
The Duchenne’s treatment made by Sarepta (eteplirsen) has been in the news this week, as a troubling example of the FDA lowering its bar for approval of new medicines. The FDA expert advisory panel...
View ArticleAn audio interview with The Conversation, on smashing the walls of the Ivory...
The Conversation is a great media outlet, because it’s run by academic nerds, but made for everyone. I had a nice time chatting with them last week: we discussed transparency, data sharing, statins,...
View ArticleYou should totally watch this entire day of the IJE conference
Today marks the end of an era. The International Journal of Epidemiology used to be a typical hotchpotch of isolated papers on worthy subjects. Occasionally, some were interesting, or related to your...
View Article“Transparency, Beyond Publication Bias”. A video of my...
People often talk about “trials transparency” as if this means “all trials must be published in an academic journal”. In reality, true transparency goes much further than this. We need Clinical Study...
View ArticleHow many epidemiologists does it take to change a lightbulb?
Robin Ince just asked if I know any epidemiologist lightbulb jokes. I wrote this for him. How many epidemiologists does it take to change a lightbulb? We’ve found 12,000 switches hidden around the...
View ArticleMeaningful Transparency Commitments: the WHO Joint Statement from Trial Funders
By now I hope you all know about the ongoing global scandal of clinical trial results being left unpublished, and of course our AllTrials campaign. Doctors, researchers, and patients cannot make truly...
View ArticleHow do the world’s biggest drug companies compare, in their...
Here’s a paper, and associated website, that we launch today: we have assessed, and then ranked, all the biggest drug companies in the world, to compare their public commitments on trials transparency....
View ArticleEvidence to House of Commons Sci Tech Select Committee on Research Integrity
Sorry not to be in regular blogging mode at the moment. Here’s a video of our evidence session to parliament, where they are running an inquiry into research integrity. I think clinical trials are the...
View Article
More Pages to Explore .....